1Dankook University College of Medicine, Cheonan, Korea
2Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Korea
3Research Institute of Healthcare Bigdata, Dankook University College of Medicine, Cheonan, Korea
© 2024, Korean Society of Epidemiology
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Exposure | Source database |
|
---|---|---|
PubMed | Web of Science | |
Climate change | (‘disabled’[Title/Abstract] or ‘disability’[Title/Abstract]) & (‘heat’[Title/Abstract] OR ‘cold’[Title/Abstract] OR ‘climate change’[Title/Abstract]) AND (humans[Filter]) AND (english[Filter] OR korean[Filter]) AND (2000:2023[pdat]) NOT (review[Publication Type]) NOT (systematic review[Publication Type]) NOT (DALY*[Title/Abstract]) NOT (randomized clinical trial [Publication Type]) | (AB=(disab*)) AND (AB=(heat) OR AB=(cold) OR AB=(climate change)) AND ((LA=English) or LA=(Korean)) and (DT=(article)) not (AB=(burden)) not (AB=DALY*) not (AB=(disability-adjusted life years)) not (TI=review) not (TI=device) not (TI=trial) |
Air pollution | (disab*[Title/Abstract] AND (“particulate matter”[Title/Abstract] OR “pm”[Title/Abstract] OR “ozone”[Title/Abstract] OR “air pollutant”[Title/Abstract] OR “air pollution”[Title/Abstract] OR “sulfur oxide”[Title/Abstract] OR “nitrogen oxide”[Title/Abstract]) AND (english[Filter] OR korean[Filter]) AND (2000:2023[pdat]) AND (humans[Filter]) NOT (review[Publication Type]) NOT (systematic review[Publication Type]) NOT (DALY*[Title/Abstract]) NOT (clinical trial[Publication Type])) | (AB=disab*) AND (AB=(particulate matter) OR AB=(pm) OR AB=(ozone) OR AB=(air pollutant) OR AB=(air pollution) OR AB=(sulfur oxide) OR AB=(nitrogen oxide)) AND ((LA=english) OR LA=korean) and (DT=(article)) not (AB=(burden)) not (AB=DALY*) not (AB=(disability-adjusted life years)) not (TI=trial) |
Categories | Items | Climate change (score) |
Air pollution (score) |
||
---|---|---|---|---|---|
All | Awarded | All | Awarded | ||
All | |||||
Score (Min-Max) | 9 | 6-7 | 9 | 8-9 | |
Case-control study/case cross-over design | |||||
Selection | Is the case definition adequate? | 6 | 6 | 3 | 3 |
Representativeness of the cases | 6 | 5 | 3 | 3 | |
Selection of controls | 6 | 5 | 3 | 3 | |
Definition of controls | 6 | 6 | 3 | 3 | |
Comparability | Comparability of cases and controls on the basis of the design or analysis | 12 | 7 | 6 | 3 |
Exposure | Ascertainment of exposure with record | 6 | 6 | 3 | 2 |
Same method of ascertainment for cases and controls | 6 | 6 | 3 | 3 | |
Non-response rate | 6 | 0 | 3 | 0 | |
Cohort study | |||||
Selection | Representativeness of the exposed cohort | 2 | 2 | 4 | 3 |
Selection of the non-exposed cohort | 2 | 2 | 4 | 4 | |
Ascertainment of exposure | 2 | 2 | 4 | 4 | |
Demonstration that outcome of interest was not present at start of study | 2 | 2 | 4 | 4 | |
Comparability | Comparability of cohorts on the basis of the design or analysis | 4 | 4 | 8 | 8 |
Outcome | Assessment of outcome | 2 | 2 | 4 | 4 |
Was follow-up long enough for outcomes to occur | 2 | 2 | 4 | 3 | |
Adequacy of follow-up of cohorts | 2 | 1 | 4 | 4 |
Study | Country | Study design/duration | Study subject | Exposure | Comparator | Health outcome |
---|---|---|---|---|---|---|
Climate change | ||||||
Petridou et al., 2003 [18] | Greece | Case-control study/1996-2000 | Children with disability | Winter (Oct to Mar) | Non-disabled children | Injury |
Holstein et al., 2005 [19] | France | Cohort study/2000-2003 | Nursing home residents with severe disabilities | Heat wave | Nursing home patients with mild disabilities | Mortality |
Laverdière et al., 2016 [20] | Canada | Cohort study/2006-2010 | Older adults requiring assistance in activities of daily living | Heat wave | Older adults | Heat-related health outcome |
Hyrkäs-Palmu et al., 2018 [21] | Finland | Cross-sectional study/2007 and 2012 | Patients with asthma and allergic rhinitis | Cold weather in Finland | No asthma or allergic rhinitis | Functional disability, exacerbation of health problem |
Coates et al., 2022 [24] | Australia | Ecological study/2001-2018 | Presence of disabilities (physical or mental) | Heat wave (2009 and 2014) | Non-disabled | Mortality |
Grineski et al., 2022 [22] | USA | Cross-sectional study/2021 | People with disabilities | Winter storm Uri | Non-disabled | Post-traumatic stress |
Grineski et al., 2023 [23] | USA | Cross-sectional study/2021 | People with disabilities | Winter storm Uri | Non-disabled, not impacted by Uri | Anxiety and depression |
Kim et al., 2023 [25] | Korea | Case-crossover design/2002-2019 | People with disabilities | Non-optimal temperatures (extreme heat, extreme cold) | Non-disabled | Hospitalization for cardiovascular disease |
Air pollution | ||||||
Cournane et al., 2017 [26] | Ireland | Cohort study/2002-2015 | People with chronic disabling disease (score=4) | PM10, SO2, NOx | People with chronic disabling disease (score=1, 2, 3) | 30-day hospital mortality |
Zhang et al., 2019 [30] | China | Cross-sectional study/2015 | Individuals aged 60 yr or older with disabilities | PM2.5, PM10, SO2, NO2, O3, CO | Individuals aged 60 yr or older without disabilities | Obesity and abdominal obesity |
deSouza et al., 2021 [31] | USA | Time-stratified case-crossover design/2000-2012 | Medicaid beneficiary | PM2.5 | Medicare enrollee not eligible for Medicaid | Cardiovascular disease |
Kim et al., 2022 [32] | Korea | Time-stratified case-crossover design/2002-2015 | People with disabilities | PM10, SO2, NO2, O3, CO | Severity and type of disability | Cardiovascular disease |
Li et al., 2022 [27] | China | National longitudinal study/2013-2019 | Patients with stroke | O3 | Stroke (change in modified ranking scale) | Poststroke neurological disability |
Feng et al., 2023 [28] | China | Cohort study/2017-2021 | Individuals aged 60 yr or older with severe disabilities | Residential greenness (mediator: PM2.5, NO2, CO, SO2, O3) | Individuals aged 60 yr or older with mild disabilities | Mortality |
Lu et al., 2023 [29] | China | National multicenter longitudinal study/2013-2019 | Patients with stroke | Five components (SO42-, NO3-, NH4+, organic matter, and black carbon) | Stroke (change in modified ranking scale) | Poststroke functional disability |
Study | Risk factor | Health outcome | Study subject | Type of effect | Effect size | 95% CI |
Exposure level/reference | ||
---|---|---|---|---|---|---|---|---|---|
LL | UL | ||||||||
Hot weather | |||||||||
Holstein et al., 2005 [19] | Heat wave in 2003 | Mortality | Disabled patients in nursing homes | Respiratory insufficiency vs. others | Mortality rate ratio | 4.74 | 3.03 | 7.42 | Before heat wave |
2.14 | 1.10 | 4.17 | Heat wave | ||||||
1.20 | 0.53 | 2.69 | After heat wave | ||||||
Dementia vs. others | 1.17 | 0.85 | 1.63 | Before heat wave | |||||
0.89 | 0.66 | 1.21 | Heat wave | ||||||
1.51 | 1.10 | 2.07 | After heat wave | ||||||
Parkinson disease vs. others | 1.43 | 0.84 | 2.42 | Before heat wave | |||||
1.10 | 0.61 | 1.98 | Heat wave | ||||||
2.04 | 1.33 | 3.14 | After heat wave | ||||||
Terminal renal insufficiency vs. others | 1.46 | 0.65 | 3.28 | Before heat wave | |||||
1.28 | 0.53 | 3.12 | Heat wave | ||||||
1.66 | 0.82 | 3.36 | After heat wave | ||||||
Epilepsy vs. others | 1.28 | 0.60 | 2.72 | Before heat wave | |||||
1.27 | 0.60 | 2.70 | Heat wave | ||||||
1.43 | 0.74 | 2.79 | After heat wave | ||||||
Psychotic states vs. others | 0.93 | 0.64 | 1.33 | Before heat wave | |||||
0.93 | 0.65 | 1.34 | Heat wave | ||||||
1.13 | 0.83 | 1.54 | After heat wave | ||||||
Severe or complex chronic disease vs. others | 2.52 | 1.86 | 3.41 | Before heat wave | |||||
1.34 | 1.03 | 1.75 | Heat wave | ||||||
1.60 | 1.26 | 2.04 | After heat wave | ||||||
Laverdière et al., 2016 [20] | Hot day (maximal temperature ≥30°C) between 2006 and 2010 | Heat-related health outcome: emergency department presentations, hospitalization, or mortality | Older adults living in Quebec | Needs help in activities of daily living | Odds ratio | 2.19 | 1.03 | 4.67 | |
Cognitive impairment | 1.22 | 0.23 | 6.53 | ||||||
Coates et al., 2022 [24] | Heat wave | Mortality with heart problem | Presence of physical disabilities | Fatality ratio | 2.9 | - | - | Vs. non-disabled | |
Mortality with respiratory problems | 0.8 | - | - | ||||||
Mortality with obesity | 0.4 | - | - | ||||||
Mortality with kidney disease | 0.4 | - | - | ||||||
Mortality with mobility problems | 0.3 | - | - | ||||||
Mortality with diabetes | 0.3 | - | - | ||||||
Mortality with cerebrovascular disease | 0.1 | - | - | ||||||
Mortality with others | 1.5 | - | - | ||||||
Kim et al., 2023 [25] | Non-optimal temperatures (extremely hot, 99th percentile) | Hospitalization for cardiovascular disease | People with disability | Relative risk | 0.99 | 0.87 | 1.12 | 20ºC as reference | |
Non-disabled | 1.07 | 0.99 | 1.15 | ||||||
Cold weather | |||||||||
Petridou et al., 2003 [18] | Cold weather (Oct-Mar) | Injury | Disabled children vs. non-disabled children | Odds ratio | 1.37 | 1.06 | 1.75 | Apr-Sep as reference | |
Hyrkäs-Palmu et al., 2018 [21] | Cold weather | Cold-related functional disability | Asthma with allergic rhinitis | Men | Prevalence ratio | 1.16 | 0.90 | 1.50 | Vs. no asthma or allergic rhinitis |
Helsinki -6.8 to 17.7ºC | Women | 1.40 | 1.12 | 1.76 | |||||
Asthma without allergic rhinitis | Men | 1.29 | 0.93 | 1.80 | |||||
Sodankylä -15.8 to 13.9°C | Women | 1.36 | 0.92 | 2.02 | |||||
Exacerbation of health problem | Asthma with allergic rhinitis | Men | 4.02 | 2.89 | 5.59 | ||||
Women | 4.60 | 3.69 | 5.73 | ||||||
Asthma without allergic rhinitis | Men | 4.28 | 2.88 | 6.36 | |||||
Women | 3.77 | 2.67 | 5.34 | ||||||
Grineski et al., 2022 [22] | Winter storm Uri | Post-traumatic stress | People with disability | Odds ratio | 4.40 | 2.71 | 7.14 | Vs. non-disabled | |
Grineski et al., 2023 [23] | Winter storm Uri | Anxiety | People with disability and impacted by Uri | Odds ratio | 6.91 | 3.26 | 14.67 | Vs. non-disabled and not impacted by Uri | |
Depression | 6.01 | 2.62 | 13.80 | ||||||
Kim et al., 2023 [25] | Non-optimal temperatures (extreme cold) | Hospitalization for cardiovascular disease | People with disability | Relative risk | 1.22 | 1.13 | 1.32 | 30th percentile vs. 20ºC | |
1.11 | 1.01 | 1.21 | 5th percentile vs. 20ºC | ||||||
Non-disabled | 1.09 | 0.97 | 1.23 | 1st percentile vs. 20ºC |
Study | Exposure | Outcome | Subjects | Type of effect | Effect size | 95% CI | Unit increase/exposure level | |
---|---|---|---|---|---|---|---|---|
Cournane et al., 2017 [26] | PM10 | 30-day hospital mortality | People with chronic disabling disease - low | Mortality (%) | 10.8 | - | - | Quintile 1 |
16.9 | - | - | Quintile 5 | |||||
People with chronic disabling disease - high | 11.6 | - | - | Quintile 1 | ||||
22.2 | - | - | Quintile 5 | |||||
Zhang et al., 2019 [30] | AQI | Obesity | People with disabilities | Odds ratio | 1.27 | 1.02 | 1.57 | Interaction term (AQI*disability) |
Abdominal obesity | 1.27 | 1.06 | 1.54 | |||||
deSouza et al., 2021 [31] | PM2.5 | Hospitalization rates for CVD | Adults receiving Medicaid (low income and disabled) | % change | 0.90 | 0.60 | 1.10 | 10 µg/m3 |
Adults not receiving Medicaid | 0.80 | 0.60 | 0.90 | |||||
Kim et al., 2022 [32] | PM10 | Hospitalization rates for CVD | Disability | % change | 10 µg/m3 at lag03 | |||
Non-disabled | 0.00 | -0.50 | 0.50 | |||||
People with disabilities | 1.90 | 0.70 | 3.20 | |||||
Type of disability | ||||||||
Physical | 1.40 | -0.60 | 3.40 | |||||
Brain lesion | 2.70 | 0.50 | 5.00 | |||||
Visual | 3.00 | -1.00 | 7.10 | |||||
Hearing | 1.60 | -0.25 | 5.90 | |||||
Others | 1.30 | -1.90 | 4.60 | |||||
Severity | ||||||||
Mild | 1.40 | -0.20 | 2.90 | |||||
Severe | 3.00 | 0.90 | 5.00 | |||||
Li et al., 2022 [27] | O3 | Increased mRS score vs. unchanged or decreased mRS score | Patients with stroke | Odds ratio | 1.23 | 1.09 | 1.37 | 10 µg/m3 (peak season) |
1.28 | 1.09 | 1.52 | 10 µg/m3 (annual mean) | |||||
Feng et al., 2023 [28] | Enhanced vegetation index within the 500 m buffer zone (EVI500m) | Mortality | Mild–moderate disability | Hazard ratio | Reference | (0.00, 0.27) | ||
0.86 | 0.80 | 0.91 | (0.27, 0.31) | |||||
Mediator: PM2.5, NO2, CO, SO2, and O3 | 0.73 | 0.65 | 0.81 | (0.31, 0.38) | ||||
0.63 | 0.55 | 0.75 | (0.38, 0.72) | |||||
Severe disability | Reference | (0.00, 0.27) | ||||||
0.95 | 0.92 | 0.97 | (0.27, 0.31) | |||||
0.89 | 0.85 | 0.94 | (0.31, 0.38) | |||||
0.86 | 0.80 | 0.91 | (0.38, 0.72) | |||||
Lu et al., 2023 [29] | Organic matter | Poststroke functional disability (change in mRS scores) | Patients with stroke | Point increase | 0.062 | 0.013 | 0.111 | Interquartile range |
Black carbon | 0.012 | -0.030 | 0.053 | |||||
NO3- | -0.002 | -0.075 | 0.071 | |||||
NH4+ | 0.008 | -0.056 | 0.072 | |||||
SO42- | 0.057 | 0.003 | 0.112 |
Min, minimum; Max, maximum.
PM, particulate matter; O3, ozone; NO, nitrous oxide; NH4+, ammonium; SO42-, sulfate; NO3-, nitrate; CO, carbon monoxide; SO2, sulfur dioxide; NO2, nitrogen dioxide; PM2.5, particulate matter smaller than 2.5 μm in diameter; PM10, particulate matter less than 10 μm in diameter.
LL, lower limit; UL, upper limit.
AQI, Air Quality Index; CVD, cardiovascular disease; mRs, modified ranking scale; PM, particulate matter; O3, ozone; NO, nitrous oxide; NH4+, ammonium; SO42-, sulfate; NO3-, nitrate; CO, carbon monoxide; SO2, sulfur dioxide; NO2, nitrogen dioxide; PM2.5, PM smaller than 2.5 μm in diameter; PM10, PM less than 10 μm in diameter.